StonvexLoading…
StonvexStonvexStonvexCore line items from TSQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $427.38M | $450.98M | $454.23M | $463.08M |
Operating Income | $44.20M | $21.69M | $-19.14M | $55.59M |
Net Income | $-11.52M | $-12.70M | $-44.96M | $12.34M |
EPS (Diluted) | $-0.71 | $-0.81 | $-2.68 | $0.68 |
Total Assets | $528.62M | $580.41M | $652.05M | $744.52M |
Total Liabilities | $569.61M | $608.86M | $642.14M | $675.44M |
Cash & Equivalents | $4.76M | $32.99M | $61.05M | $43.42M |
Free Cash Flow OCF − CapEx | $15.38M | $31.31M | $52.85M | $34.36M |
Shares Outstanding | 16.18M | 16.70M | 16.76M | 18.20M |